{"article_title": "Medtronic to join fleet of US companies jumping ship for Europe", "article_keywords": ["europe", "giant", "join", "deal", "proposed", "tax", "companies", "covidian", "rate", "jumping", "including", "reincorporate", "fleet", "ship", "corporate", "medtronic"], "article_url": "http://nypost.com/2014/06/15/medtronic-to-join-fleet-of-us-companies-jumping-ship-for-europe/", "article_text": "Another US corporate giant is looking to re-incorporate in Europe \u2014 and thumb its nose at Uncle Sam.\n\nMedical device-maker Medtronic is in advanced talks to shell out more than $45 billion to acquire rival Covidian, according to reports, in a deal whose key attraction is to lower its tax bill.\n\nMinnesota-based Medtronic makes pacemakers and spinal devices, while Covidian specializes in surgical devices including staplers, sutures and needles.\n\nWhile there could be savings created through the elimination of duplicate back-office services and sales teams, the really big reductions would come with Medtronic, which is subject to the US corporate tax rate of 35 percent, reincorporating itself in lightly taxed Ireland, where Covidian is based \u2014 despite keeping most of its operations in Massachusetts.\n\nCovidian is now subject to Ireland\u2019s main corporate tax rate of 12.5 percent, which allows it to be more profitable than its US rivals, according to analysts.\n\nMedtronic also is looking to make use of more than $14 billion in cash it has stashed overseas in order to avoid paying US taxes on it. Last year, Medtronic\u2019s effective tax rate was 18 percent, lowered by keeping its foreign earnings outside the US.\n\nThe Medtronic-Covidian deal could be announced as soon as Monday, according to reports.\n\nThe proposed deal, known as a \u201ctax inversion,\u201d would be the fifth tax-aversion takeover announced this year, with medical companies in particular making the move, citing fears that ObamaCare will cut into profits.\n\nThere were four tax-aversion mergers in all of 2013.\n\nOther big firms, including Liberty Global and banana giant Chiquita, have also lately cut deals to reincorporate outside the US. Meanwhile, members of Congress have signaled they want to close the tax loophole.\n\n\u201cThese transactions are about tax avoidance, plain and simple,\u201d Sen. Carl Levin (D-Mich.), the lead sponsor of a bill that would close the aversion loophole, said last month. \u201cThe Treasury is bleeding red ink, and we can\u2019t wait for comprehensive tax reform to stop the bleeding.\u201d\n\nDrug giant Pfizer recently scuttled a proposed $120 billion deal to acquire its UK-based rival AstraZeneca, a move that would have spurred a tax windfall worth billions.\n\nMeanwhile, Illinois-based drugstore chain Walgreen is set to acquire British-based drug chain Alliance Boots next year. Walgreen is being pressured by shareholders, including the hedge fund Jana Partners, to reincorporate in Switzerland to avoid US taxes once the deal is done.\n\nCritics, meanwhile, have blasted Walgreen\u2019s proposed dodge, noting that the chain gets nearly a quarter of its business from the government\u2019s Medicare and Medicaid programs.", "article_metadata": {"application-name": "New York Post", "twitter": {"description": "Another US corporate giant is looking to re-incorporate in Europe \u2014 and thumb its nose at Uncle Sam.\nMedical device-maker Medtronic is in advanced talks to shell out more than $45 billion to acquire", "title": "Medtronic to join fleet of US companies jumping ship for Europe", "image": "https://thenypost.files.wordpress.com/2014/06/medtronic-covidien_talks.jpg?quality=90&strip=all&w=664&h=441&crop=1", "creator": "@jamescovert1", "site": "@nypost", "card": "summary_large_image"}, "parsely-metadata": "{\"post_id\":\"nypost-5865171\"}", "sailthru.tags": "corporate-taxes,corporations,", "msapplication-task": "name=Subscribe;action-uri=http://nypost.com/feed/;icon-uri=http://0.gravatar.com/blavatar/0b14d9dbf0c711522a906102b60f3da0?s=16", "generator": "WordPress.com", "sailthru.date": "2014-06-15 23:32:42", "sailthru.title": "Medtronic to join fleet of US companies jumping ship for\u00a0Europe", "nypost-section": "Business", "msapplication-window": "width=device-width;height=device-height", "sailthru.image.thumb": "https://thenypost.files.wordpress.com/2014/06/medtronic-covidien_talks.jpg?quality=90&strip=all&w=231&h=154&crop=1", "description": "Another US corporate giant is looking to re-incorporate in Europe \u2014 and thumb its nose at Uncle Sam.\r\n\r\nMedical device-maker Medtronic is in advanced talks to shell out more than $45 billion to acquire rival Covidian, according to reports, in a deal whose key attraction is to lower its tax bill.\r\n\r\nMinnesota-based Medtronic makes pacemakers and spinal devices, while Covidian specializes in surgical devices including staplers, sutures and needles.\r\n\r\nWhile there could be savings created through the elimination of duplicate back-office services and sales teams, the really big reductions would come with Medtronic, which is subject to the US corporate tax rate of 35 percent, reincorporating itself in lightly taxed Ireland, where Covidian is based \u2014 despite keeping most of its operations in Massachusetts.\r\n\r\nCovidian is now subject to Ireland\u2019s main corporate tax rate of 12.5 percent, which allows it to be more profitable than its US rivals, according to analysts.\r\n\r\nMedtronic also is looking to make use of more than $14 billion in cash it has stashed overseas in order to avoid paying US taxes on it. Last year, Medtronic\u2019s effective tax rate was 18 percent, lowered by keeping its foreign earnings outside the US.\r\n\r\nThe Medtronic-Covidian deal could be announced as soon as Monday, according to reports.\r\n\r\nThe proposed deal, known as a \u201ctax inversion,\u201d would be the fifth tax-aversion takeover announced this year, with medical companies in particular making the move, citing fears that ObamaCare will cut into profits.\r\n\r\nThere were four tax-aversion mergers in all of 2013.\r\n\r\nOther big firms, including Liberty Global and banana giant Chiquita, have also lately cut deals to reincorporate outside the US. Meanwhile, members of Congress have signaled they want to close the tax loophole.\r\n\r\n\u201cThese transactions are about tax avoidance, plain and simple,\u201d Sen. Carl Levin (D-Mich.), the lead sponsor of a bill that would close the aversion loophole, said last month. \u201cThe Treasury is bleeding red ink, and we can\u2019t wait for comprehensive tax reform to stop the bleeding.\u201d\r\n\r\nDrug giant Pfizer recently scuttled a proposed $120 billion deal to acquire its UK-based rival AstraZeneca, a move that would have spurred a tax windfall worth billions.\r\n\r\nMeanwhile, Illinois-based drugstore chain Walgreen is set to acquire British-based drug chain Alliance Boots next year. Walgreen is being pressured by shareholders, including the hedge fund Jana Partners, to reincorporate in Switzerland to avoid US taxes once the deal is done.\r\n\r\nCritics, meanwhile, have blasted Walgreen\u2019s proposed dodge, noting that the chain gets nearly a quarter of its business from the government\u2019s Medicare and Medicaid programs.", "msapplication-tooltip": "Your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.", "fb": {"pages": 134486075205}, "msvalidate.01": "8188997BC82071CE07AB711B5675CE54", "article": {"publisher": "https://www.facebook.com/nypost", "published_time": "2014-06-16T03:32:42+00:00", "modified_time": "2014-06-16T19:39:39+00:00"}, "sailthru.description": "Another US corporate giant is looking to re-incorporate in Europe \u2014 and thumb its nose at Uncle Sam.", "copyright": "Copyright 2016 NYP Holdings. All rights reserved.", "og": {"site_name": "New York Post", "description": "Another US corporate giant is looking to re-incorporate in Europe \u2014 and thumb its nose at Uncle Sam. Medical device-maker Medtronic is in advanced talks to shell out more than $45 billion to acquir\u2026", "title": "Medtronic to join fleet of US companies jumping ship for Europe", "url": "http://nypost.com/2014/06/15/medtronic-to-join-fleet-of-us-companies-jumping-ship-for-europe/", "image": {"secure_url": "https://i0.wp.com/thenypost.files.wordpress.com/2014/06/medtronic-covidien_talks.jpg?quality=90&strip=all&ssl=1", "identifier": "https://thenypost.files.wordpress.com/2014/06/medtronic-covidien_talks.jpg?quality=90&strip=all&w=1200"}, "locale": "en_US", "type": "article"}, "p": {"domain_verify": "44b526edc36ffbcc163412ee9fe42833"}, "google-site-verification": "Y35rxQGMDF8RBK0PXe_b3H0oZ6qw1a5l3oI4l_YXIcE", "sailthru.image.full": "https://thenypost.files.wordpress.com/2014/06/medtronic-covidien_talks.jpg?quality=90&strip=all"}, "article_summary": "Another US corporate giant is looking to re-incorporate in Europe \u2014 and thumb its nose at Uncle Sam.\nLast year, Medtronic\u2019s effective tax rate was 18 percent, lowered by keeping its foreign earnings outside the US.\nCovidian is now subject to Ireland\u2019s main corporate tax rate of 12.5 percent, which allows it to be more profitable than its US rivals, according to analysts.\nMinnesota-based Medtronic makes pacemakers and spinal devices, while Covidian specializes in surgical devices including staplers, sutures and needles.\nThe proposed deal, known as a \u201ctax inversion,\u201d would be the fifth tax-aversion takeover announced this year, with medical companies in particular making the move, citing fears that ObamaCare will cut into profits."}